69. Einhorn, D. American College of Endocrinology position statement on the
insulin resistance syndrome / D.Einhorn, G.M. Reaven, R.H. Cobin, et al. //
Endocr Pract. - 2003. - Vol. 9. - P.237-252.
70. Emberson J. Evaluating the impact of population and high-risk strategies for the
primary prevention of cardiovascular disease / J. Emberson, P. Wincup, R.
Morris, et al. // Eur Heart J. - 2004. - Vol. 5. - P.58-66.
71. Ferrannini, E. Effect of fatty acids on glucose production and utilization in man /
E. Ferrannini, E.J. Barrett, S. Bevilacqva, et al. // J Clin Invest. - 1983. - Vol. 72.
- P . 1737-1747.
72. Ford, E.S. Explaining the decrease in US deaths from coronary disease 1980-
2000 / E.S Ford, U.A. Ajani, Croft J.B. // N Engl J Med. - 2007. - Vol. 356. -
P.2388-2398.
73. Ford, E.S. Prevalence of the metabolic syndrome among US adults: findings
from the third National Health and Nutrition Examination Survey / Ford E.S.,
Giles W.H., Dietz W.H. - JAMA. - 2002. - Vol. 287. - P.356-359.
74. Ford, I. Long-Term Follow-up of the West of Scotland Coronary Prevention
Study / I. Ford, H. Murray, C.J. Paccard, et al. // N Engl J Med. - 2007. - Vol.
357. - P.1477-1486.
75. Frick, M.H. Helsinki Heart Study: primary-prevention trial with gemfibrozil in
middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors,
and incidence of coronary heart disease / M.H. Frick, O. Elo, K. Haapa, et al. // N
Engl J Med. - 1987. - Vol. 317. - P.1237-1245.
76. Fruchart, J.C. PPARS, metabolic disease and atherosclerosis / J.C. Fruchart, B.
Staels, P. Duriez // Pharmacol Res. - 2001. - Vol. 44. - P.345-352.
77. Fuster, V. Acute coronary syndromes: biology / V. Fuster, Z.A. Fayard, J.J.
Badimon // Lancet. - 1999. - Vol. 353 (SII). - P.5-9.
78. Genuth, S. Follow-up report on the diagnosis of diabetes mellitus. The Expert
Committee on the Diagnosis and Classification of Diabetes Mellitus / S. Genuth,
K.G. Alberti, P. Bennett, et al. // Diabetes Care. - 2003. - Vol. 26. - P.3160-
3167.
91
